Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open-label Trial to Evaluate Efficacy of Lyophilized Fecal Microbiota Transplantation for Treatment of Recurrent C. Difficile Infection

NCT03834038 is registered in ClinicalTrials.gov with Vancouver Island Health Authority as lead sponsor.

NCT NCT03834038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03834038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open-label Trial to Evaluate Efficacy of Lyophilized Fecal Microbiota Transplantation for Treatment of Recurrent C. Difficile Infection
Lead sponsor
Vancouver Island Health Authority
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2015
Completion date
March 17, 2020
Enrollment
158 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent clostridium difficile infection